J05AB06 • ganciclovir • Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors
Ganciclovirum is an antiviral medication used for the treatment and prevention of cytomegalovirus (CMV) infections in immunocompromised patients, such as those with HIV/AIDS or transplant recipients. It works by inhibiting viral DNA replication.
The medication is available as an injectable solution or oral capsules, and treatment must be administered under the supervision of a specialist. Ganciclovirum is effective in reducing viral load and preventing severe complications.
Common side effects include nausea, diarrhea, decreased white blood cell count, and fatigue. It is important for patients to be monitored to prevent hematologic toxicity.
Ganciclovirum is an essential therapeutic option for patients with severe CMV infections, helping to improve their prognosis.
Substance: ganciclovir
Date of last drug list: 01-04-2020
Commercial code: W61213001
Concentration: 500mg
Pharmaceutical form: powder infusion solution
Quantity: 1
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).